Sweden
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
44.95%
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
2 |
34.66%
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
3 |
32.07%
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
4 |
24.73%
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
5 |
23.16%
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
6 |
20.83%
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
7 |
18.37%
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
8 |
14.14%
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
9 |
13.06%
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
10 |
10.74%
|
Dec. 31, 2024 | USD 41.47 | -0.80% |
|
Sweden |
|
11 |
10.74%
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
12 |
9.09%
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
13 |
8.43%
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
14 |
7.39%
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
15 |
7.24%
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
16 |
7.09%
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
17 |
6.47%
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
18 |
4.29%
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
19 |
3.92%
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
20 |
2.14%
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
21 |
-5.01%
|
Dec. 31, 2023 | USD 0.14 | 2.05% |
|
Sweden |
|
22 |
-7.12%
|
Dec. 31, 2023 | USD 0.81 | -4.47% |
|
Sweden |
|
23 |
-15.51%
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
24 |
-18.34%
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
25 |
-20.95%
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
26 |
-22.21%
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
27 |
-38.22%
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
28 |
-93.57%
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
29 |
-102.79%
|
Dec. 31, 2023 | USD 19.80 | -1.20% |
|
Sweden |
|
30 |
-152.24%
|
Dec. 31, 2023 | USD 0.31 | 1.24% |
|
Sweden |
|
31 |
-165.73%
|
Dec. 31, 2023 | USD 0.84 | -2.95% |
|
Sweden |
|
32 |
-355.30%
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
33 |
-381.39%
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
|
34 |
-393.45%
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
35 |
-461.04%
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
36 |
-540.88%
|
Dec. 31, 2023 | USD 3.01 | -2.55% |
|
Sweden |
|
37 |
-560.24%
|
Dec. 31, 2023 | USD 0.54 | -2.24% |
|
Sweden |
|
38 |
-641.65%
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
39 |
-643.30%
|
Dec. 31, 2023 | USD 0.21 | 1.47% |
|
Sweden |
|
40 |
-675.99%
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
41 |
-688.99%
|
Dec. 31, 2023 | USD 0.16 | 9.53% |
|
Sweden |
|
42 |
-697.66%
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
|
43 |
-1,167.55%
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
44 |
-1,768.66%
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
45 |
-3,128.57%
|
Dec. 31, 2023 | USD 1.30 | -5.64% |
|
Sweden |
|
46 |
-4,812.54%
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
47 |
-6,119.26%
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
48 |
-6,269.47%
|
Dec. 31, 2023 | USD 0.09 | -2.98% |
|
Sweden |
|
49 |
-6,752.83%
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
50 |
-70,111.32%
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
The Healthcare company in Sweden with the highest EBIT Margin is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at 44.95%.
The Healthcare company in Sweden with the lowest EBIT Margin is OncoZenge AB (publ) (Stockholm Stock Exchange: ONCOZ.ST) at -530,066.67%.
The top 10 Healthcare companies in Sweden by EBIT Margin are BioArctic AB (publ), Genovis AB (publ.), Camurus AB (publ), CellaVision AB (publ), ADDvise Group AB (publ), Sleep Cycle AB (publ), Swedish Orphan Biovitrum AB (publ), Stille AB, Vimian Group AB (publ) and Xvivo Perfusion AB (publ).
The bottom 10 Healthcare companies in Sweden by EBIT Margin are OncoZenge AB (publ), Diamyd Medical AB (publ), Lipum AB (publ), SpectraCure AB (publ), Kancera AB (publ), Alzinova AB (publ), Nanologica AB (publ), IRLAB Therapeutics AB (publ), Biovica International AB (publ) and Intervacc AB (publ).